Repository drugs. VII. N-Allylidene-4,4'-sulfonyldianiline and N-(benzylidene- and -1-naphthylmethylene)-N'-methylene-4,4'-sulfonyldianiline polymers with prolonged antimalarial and antileprotic action.
D000814:Aniline Compounds / Q000008:administration & dosage / Q000138:chemical synthesis* / Q000378:metabolism; D000818:Animals; D003692:Delayed-Action Preparations; D007918:Leprosy / Q000188:drug therapy*; D008288:Malaria / Q000188:drug therapy*; D051379:Mice; D011108:Polymers; D051381:Rats; D013450:Sulfones / Q000008:administration & dosage / Q000138:chemical synthesis* / Q000378:metabolism
D000814:Aniline Compounds; D003692:Delayed-Action Preparations; D011108:Polymers; D013450:Sulfones